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a b s t r a c t 
We previously reported that a restrictive N-terminal truncation of cardiac troponin I (cTnI-ND) is up-
regulated in the heart in adaptation to hemodynamic stresses. Over-expression of cTnI-ND in the hearts
of transgenic mice revealed functional beneﬁts such as increased relaxation and myocardial compliance.
In the present study, we investigated the subsequent effect on myocardial remodeling. The alpha-
smooth muscle actin ( α-SMA) isoform is normally expressed in differentiating cardiomyocytes and
is a marker for myocardial hypertrophy in adult hearts. Our results show that in cTnI-ND transgenic
mice of between 2 and 3 months of age (young adults), a signiﬁcant level of α-SMA is expressed in the
heart as compared with wild-type animals. Although blood vessel density was increased in the cTnI-ND
heart, the mass of smooth muscle tissue did not correlate with the increased level of α-SMA. Instead,
immunocytochemical staining and Western blotting of protein extracts from isolated cardiomyocytes
identiﬁed cardiomyocytes as the source of increased α-SMA in cTnI-ND hearts. We further found that
while a portion of the up-regulated α-SMA protein was incorporated into the sarcomeric thin ﬁlaments,
the majority of SMA protein was found outside of myoﬁbrils. This distribution pattern suggests dual
functions for the up-regulated α-SMA as both a contractile component to affect contractility and as
possible effector of early remodeling in non-hypertrophic, non-failing cTnI-ND hearts. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical



















 1. Introduction 
Troponin I (TnI) is the inhibitory subunit of the troponin complex
that plays a central function in the Ca 2 + regulation of striated mus-
cle contraction [ 1 , 2 ]. Three muscle type-speciﬁc isoforms of TnI are
present in vertebrates. Cardiac TnI (cTnI) has an N-terminal extension
of ∼30 amino acids, which is not present in the fast or slow skeletal
muscle TnI isoforms. Embryonic hearts express slow skeletal muscle
TnI with a perinatal switch to solely cardiac TnI [ 2 ]. The N-terminal
extension of cTnI contains two Ser residues (Ser 23 and Ser 24 ) that are
substrates of protein kinase A (PKA), and a regulatory site downstream
of the β-adrenergic signaling pathway [ 3 ]. Therefore, the N-terminal This is an open-access article distributed under the terms of the Creative Com- 
mons Attribution-NonCommercial-No Derivative Works License, which permits non- 
commercial use, distribution, and reproduction in any medium, provided the original 
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Abbreviations: α-SMA, alpha-smooth muscle actin; cTnI, cardiac troponin I; cTnI- 
ND, N-terminal truncated cardiac troponin I; α-CA, alpha-cardiac actin; α-SKA, alpha- 
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ture. 
A posttranslational modiﬁcation of cTnI via restrictive proteolysis
was found as a molecular adaptation to cardiac stress such as that
in rats following simulated microgravity [ 4 ], and in mice with β-
adrenergic deﬁcient failing hearts [ 5 ]. This restrictive proteolysis re-
moves the cardiac-speciﬁc N-terminal extension (cTnI-ND). cTnI-ND
is detectable only at low levels in normal hearts of multiple species [ 4 ]
and the up-regulation adaptation to hemodynamic stresses indicates
a functional signiﬁcance. 
cTnI-ND preserves the core structure of TnI and remains func-
tional in the cardiac myoﬁlaments. Double transgenic mice with en-
dogenous cTnI gene deleted and solely cTnI-ND in the adult cardiac
muscle survive well, demonstrating the non-destructive nature of
cTnI-ND [ 6 ]. Transgenic mice over-expressing cTnI-ND in the hearts
have apparently normal cardiac morphology and life span [ 7 ], yet
exhibit increased myocardial relaxation and improved ventricular
ﬁlling, consistent with a regulatory effect of removing the cardiac-
speciﬁc N-terminal extension on reducing thin ﬁlament Ca 2 + sen-
sitivity and facilitated diastolic function of the cardiac muscle [ 7 ].
cTnI-ND hearts with enhanced relaxation exhibit increased systolic
function and cardiac output through the Frank–Starling mechanismf European Biochemical Societies. All rights reserved. 
























































Fig. 1. Signiﬁcant expression of α-SMA in cTnI-ND mouse heart. Ventricular muscle 
homogenates of wild type, cTnI-ND, and cTnI-K118C (a double transgenic line express- 
ing a cTnI mutant on the endogenous cTnI gene knockout background [ 13 ]) mice ( ∼80 
μg total protein / lane), or mouse bladder ( ∼5 μg total protein / lane) were analyzed 
by SDS–PAGE ( upper panel, Coomassie blue protein stain) and immunoblotting ( lower 
three panels ). The results detected a signiﬁcant level of α-SMA in cTnI-ND hearts but not 
in the wild type and cTnI-118C control hearts. Smooth muscle-speciﬁc protein markers 
h1 and h2 calponins (RAH2 blot) and SM22 were examined as controls.  7 , 8 ], providing a functional compensation in chronic heart failure 
 5 ]. 
The hemodynamic changes in cTnI-ND hearts may have effects 
n gene expression and structural remodeling in cardiomyocytes. In 
rder to explore the beneﬁcial function of cTnI-ND as a potential tar- 
et in the treatment of heart failure, it is necessary to understand 
ts potential effect on myocardial remodeling. In a search of remod- 
ling markers in cTnI-ND mouse heart, the present study focused 
n alpha-smooth muscle actin ( α-SMA), an established molecular 
arker of cardiac hypertrophy such as that provoked by aortic con- 
triction [ 9 ]. Six isoforms of actin exist in mammalian cells, which can 
e divided in three classes [ 10 ]. The beta and gamma actins, which in- 
lude β-cytosolic, γ-cytosolic, and γ-smooth muscle actin, are found 
n most cell types as major components of the cytoskeleton. Mean- 
hile, the three alpha actin isoforms, α-SMA, α-cardiac actin ( α-CA), 
nd α-skeletal muscle actin ( α-SKA), are considered components of 
he contractile apparatus in muscle cells. During cardiac develop- 
ent, the three α-actins are expressed temporally, such that α-SMA 
xpresses at the early stages and is replaced by α-SKA and α-CA in 
dult myocardium [ 11 , 12 ]. 
In experiments described here, we found an up-regulation of α- 
MA in cTnI-ND hearts and determined its tissue type and cellular dis- 
ributions. Our data demonstrate an increase in α-SMA in cardiomy- 
cytes of young cTnI-ND mice, of which only a fraction is present in 
ardiac myoﬁbrils. Our data suggest that the majority of up-regulated 
-SMA may instead be part of early remodeling affectors that occur 
efore overt adaptive changes such as hypertrophy and failure. 
. Results 
.1. Increased expression of α-SMA in cTnI-ND hearts 
All mice used in the present study were between 2 and 3 months 
ld. We have previously shown that transgenic expression of cTnI- 
D to replace endogenous cTnI does not cause hypertrophy or failure 
 5 , 7 , 8 ]. 
Immunoblots of ventricular muscle homogenates detected a sig- 
iﬁcant amount of α-SMA in cTnI-ND mouse hearts, which was not 
etectable in wild-type mouse hearts ( Fig. 1 ). α-SMA was also not de- 
ectable in the ventricular homogenate of a control double transgenic 
ouse line that expresses a mutant cTnI on the endogenous cTnI gene 
ull background (cTnI-K118C, [ 13 ]). These background controls indi- 
ate that (i) the endogenous cTnI gene null background did not con- 
ribute to the increased expression of α-SMA; and (ii) the contribution 
f vascular smooth muscle in the ventricular wall was insigniﬁcant in 
he amount of α-SMA detected in the cTnI-ND heart, which was also 
hown by the negative Western blots of calponin and SM22 ( Fig. 1 ), 
wo smooth muscle speciﬁc protein markers [ 2 , 14 ]. 
.2. Increased blood vessel density in cTnI-ND hearts 
α-SMA in adult cardiac muscle is a known marker of cardiac hyper- 
rophy [ 9 , 15 ], we have previously demonstrated that cTnI-ND hearts 
xhibit no signs of hypertrophy [ 7 ]. To investigate the signiﬁcance 
f increased α-SMA expression in the young and non-hypertrophic 
TnI-ND mouse hearts, we carried out immunohistochemical analyses 
f transverse ventricular sections using an anti- α-SMA antibody ( Fig. 
 A). The results revealed changes in the vasculature in these young 
TnI-ND mouse hearts. Quantiﬁcation of the immunohistochemical 
mages showed a signiﬁcant ( ∼23%) increase in blood vessel density 
n cTnI-ND hearts as compared to wild type controls ( Fig. 2 B). This 
nding supported a possible role for cTnI-ND to induce myocardial 
ascular remodeling without cardiac muscle hypertrophy. 
The data further showed that vessel size, i.e., cross-sectional area, 
n cTnI-ND hearts, was slightly smaller, while the relative cross- 
ectional areas of the vessel walls slightly increased, compared to wild type hearts, however neither difference was statistically sig- 
niﬁcant ( Fig 2 B). Based upon the fact that α-SMA levels in vascular 
structures was similar in cTnI-ND hearts and wild-type hearts ( Fig. 2 ), 
along with the absence of detectable smooth muscle protein mark- 
ers ( Fig. 1 ), we conclude that the signiﬁcantly increased expression 
of α-SMA in cTnI-ND hearts was not from smooth muscle cells. The 
non-detectable levels of h1- and h2-calponins in cTnI-ND hearts ( Fig. 
1 ) are also consistent with the lack of signiﬁcant contribution from 
myoﬁbroblasts or ﬁbroblasts. These cells have been reported to pro- 
liferate in remodeling cardiac muscle, such as that occurs following 
right ventricular pressure overload [ 15 ]. 
2.3. Expression of α-SMA in cTnI-ND cardiomyocytes 
To further explore the cell source of up-regulated α-SMA in cTnI- 
ND hearts, freshly isolated cardiomyocytes from cTnI-ND and wild 
type hearts were examined by immunoblot analyses. The results, con- 
sistent with the immunohistochemical staining ( Fig. 2 ), showed that 
wild-type cardiomyocytes were without detectable levels of α-SMA, 
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Fig. 2. Analysis of vasculature in wild type and cTnI-ND mouse ventricle . (A) Immuno- 
histochemical analysis of transverse heart sections from wild type and cTnI-ND hearts 
stained for α-SMA revealed vascular structures. A representative slice from a wild type 
heart is shown with magniﬁed portions from wild type and cTnI-ND hearts to demon- 
strate the level of resolution used for quantiﬁcation as described in Section 4 . (B) Vessel 
density ( upper plot ) was increased in cTnI-ND hearts in comparison with that in wild 
type hearts. However, total vessel size ( middle ) and vessel wall area ( bottom ) was not 
signiﬁcantly different between the two groups. Data are presented as mean ± SE. 
* P < 0.05. Wild type, 1149 vessels examined from 14 sections; cTnI-ND, 885 vessels 
































Fig. 3. Signiﬁcant expression of α-SMA in cTnI-ND mouse cardiomyocytes . Cardiomy- 
ocytes were isolated from 2 to 3 months old wild type and cTnI-ND mouse hearts and 
examined by SDS–PAGE ( upper panel , Coomassie blue protein stain, ∼50 μg / lane) and 
immunoblot analyses using anti- α-SMA ( lower panel ). The results detected a signiﬁ- 
cant level of α-SMA expressed in cTnI-ND but not wild type cardiomyocytes. Mobilities 
























 whereas myocytes from all cTnI-ND hearts examined contained read-
ily detectable levels of α-SMA ( Fig. 3 ), albeit with signiﬁcant variation
among animals. The variation in expression level may reﬂect the vari-
ation in myocardial adaptation to the function of cTnI-ND and remains
to be investigated. 
Immunoﬂuorescence analysis readily revealed striated distribu-
tion pattern for α-SMA immunoﬂuorescence in cTnI-ND cardiomy-
ocytes ( Fig. 4 A), whereas control staining in wild-type mouse car-
diomyocytes produced low background signals similar to no-ﬁrst-
antibody controls. In comparison to α-SMA in wild-type control
hearts, cTnI-ND cardiomyocytes were signiﬁcantly higher in ﬂuores-
cence intensity (3.3 ± 1.0-fold, Fig. 4 B). The ﬂuorescence pattern in
the permeabilized cardiomyocytes suggests that the increased α-SMA
protein detected by immunoblotting of the total protein extracts from
the isolated cardiomyocytes involves myoﬁlament association. 
The area of cTnI-ND cardiomyocytes (2274 ± 399 μm 2 ) was sim-
ilar to that of wild type cells (2543 ± 439 μm 2 , Fig. 4 C). Accordingly,
there was no correlation between the levels of α-SMA and cell size
( Fig. 4 D), conﬁrming that increased expression of α-SMA in cTnI-ND
cardiomyocytes was not accompanied by a cellular level of hypertro-
phy. 
2.4. Only a portion of the up-regulated α-SMA is localized to myoﬁbrils
In adult cardiomyocytes, alpha-actins are a major constituent of
the contractile apparatus, i.e., the thin ﬁlaments in the sarcomeres
[ 16 ]. The signiﬁcant amount of α-SMA expressed in cTnI-ND car-
diomyocytes, therefore, potentially has myoﬁlament incorporations
and functions. To investigate this hypothesis, total homogenates and
isolated myoﬁbrils from ventricular muscle of wild type and cTnI-ND
mouse hearts were examined for the relative level of α-SMA versus
total actin. 
SDS–PAGE and Western blot results showed that levels of total
actin were similar for the two groups ( Fig. 5 A). Knowing that α-SMA
was up-regulated in isolated cTnI-ND cardiomyocytes ( Fig. 3 ), we
wondered whether its level was increased proportionally in isolated
myoﬁbrils with enriched sarcomeric myoﬁlaments. When the relativedensitometry ratio of α-SMA (Western blots) to total actin (SDS-gel)
was compared between total muscle homogenate and isolated my-
oﬁbrils, a signiﬁcantly lower proportion was found in the myoﬁbrils
( Fig. 5 B). Thus, the low proportion of α-SMA observed in myoﬁbrils
isolated from cTnI-ND mouse hearts suggested that myoﬁbrils were
one source of α-SMA localization, but not the major source. An alter-
native explanation is that α-SMA in cTnI-ND cardiomyocytes, while
a component of the myoﬁbrillar complex, is structurally integrated
differently from that of α-CA, so that the two forms of actin were not
co-enriched. 
To visualize the precise overlap of α-SMA with the myoﬁbril, we
compared indirect immunoﬂuorescence for α-SMA and TnT, a pre-
dominant myoﬁbril-speciﬁc protein. Confocal imaging of immunos-
tained cTnI-ND cardiomyocytes ( Fig. 6 ) showed non-complete over-
lap between the sarcomeric patterns for the two proteins, and a non-
homogeneous appearance of α-SMA immunoﬂuorescence among
myoﬁbrils across the cellular plane. Taken with the poor biochemical
recovery of α-SMA with other myoﬁbrillar components, the double
immunoﬂuorescence staining suggests that α-SMA resides in close
proximity to the myoﬁbrils, but its participation in the contractile
function in these hearts remains to be investigated. 
3. Discussion 
Myocardial remodeling occurs in response to various physiologi-
cal and pathological conditions [ 17 ]. The mechanisms by which the
contractile properties of the cardiac muscle result in myocardial re-
modeling are not fully understood. Our present study demonstrated
and characterized an up-regulation of α-SMA in transgenic mouse
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Fig. 4. Immunoﬂuorescence microscopy analysis of α-SMA expression in cTnI-ND car- 
diomyocytes. (A) Freshly isolated cardiomyocytes from wild type and cTnI-ND hearts 
were ﬁxed on glass cover slips, stained with anti- α-SMA antibody and Alexa Fluor 
488-conjugated second antibody. No-primary-antibody controls were included. Im- 
munostained myocytes, also shown in phase contrast ( left panels ), were examined 
using identical imaging and off-line processing, which revealed signiﬁcant levels of in- 
tracellular α-SMA in cTnI-ND but not wild type cardiomyocytes. (B) Total ﬂuorescence 
intensity was determined for cells from wild type and cTnI-ND hearts by normaliz- 
ing to the average level measured in wild type cells, to correct for the variable but 
low levels of autoﬂuorescence within cardiomyocytes. Relative ﬂuorescence intensi- 
ties per cell area showed the signiﬁcantly increased expression of α-SMA in cTnI-ND 
cardiomyocytes, while cell areas were similar to that of wild type cardiomyocytes (C), 
wild type, n = 35; cTnI-ND, n = 47. Data are presented as mean ± SE, ** P < 0.01. (D) 
To determine whether anti- α-SMA immunoﬂuorescence correlated with cell surface 
area, a measure of hypertrophic growth, cardiomyocyte area-normalized intensity was 
plotted against the area of each cell. Linear regression correlation conﬁrmed that im- 
munoﬂuorescence intensity is independent of the cell size. Low levels of background 
ﬂuorescence intensity measured for wild type cells was also independent of normal- 
ized cell area (least-squares ﬁt of data, dashed line ). Inset panels show representative 
cells with relative ﬂuorescent intensity indicated on the bottom left. Wild type, N = 3; 

























Fig. 5. Limited myoﬁbril-integration of α-SMA. (A) Ventricular muscle homogenates 
(H, 40 μg / lane) and isolated ventricular myoﬁbrils (MF, protein levels adjusted to 
achieve similar actin bands on gel) were prepared from wild type and cTnI-ND mouse 
hearts and analyzed by SDS–PAGE ( upper panel) and immunoblotting ( lower two pan- 
els) using anti- α-SMA or anti-TnI antibody. (B) Anti- α-SMA immunoblot densitometry 
of total ventricular homogenates and isolated cardiac myoﬁbrils from cTnI-ND hearts 
normalized to total actin band in the SDS–PAGE gel showed signiﬁcantly lower pro- 
portion of α-SMA in the myoﬁbrils than that in the total muscle homogenates. * P < 
0.01. Wild type, N = 3; cTnI-ND, N = 3. Data are presented as mean ± SE. earts expressing cTnI-ND, a modiﬁcation in the myoﬁlament Ca 2 + - 
egulatory system shown to selectively facilitate diastolic function in 
he heart [ 5 , 7 ]. This unique model system allowed us to investigate 
he remodeling consequences of selectively increased myocardial re- 
axation with the following ﬁndings. 
.1. α-SMA expresses in cTnI-ND cardiomyocytes as an early 
emodeling response 
It has been well established that α-SMA is expressed in cardiomy- 
cytes during early stages of heart development but is soon thereafter 
eplaced by α-SKA and α-CA [ 11 , 12 ]. Reactivation of its expression is 
onsidered a potential marker of ventricular hypertrophy [ 9 , 15 , 18 ]. In 
esponse to stresses or injury, the heart can adapt through a number 
f remodeling mechanisms that are manifested clinically as changes 
n size, shape, and function [ 17 , 19 ]. Remodeling mechanisms range 
rom the reversible compensation resulting from athletic activity to 
he necrotic repair that follows infarction, and can modify cardiac 
unction over time, from initially improved output to diminished 
unction and progression to failure [ 17 ]. All myocardial remodeling is 
xpected to require early changes in gene expression, however, the 
arliest such changes have been the most difﬁcult to discover because 
nimal models often have a rapid transition into cardiac hypertrophy 
r failure. In addition, myocardial remodeling often involves apop- 
otic or necrotic cell death and ﬁbrosis [ 20 ]. 
As a unique model system, the cTnI-ND mouse hearts showed no 
igns of hypertrophy or destruction in function at the age investigated 
n the present study. Nonetheless, evidence of ventricular remodeling in the cTnI-ND hearts was indicated by the signiﬁcant increased den- 
sity but not size of the blood vessels ( Fig. 2 ). There was no increase in 
the mass of vascular wall ( Fig. 2 ) and no detection of smooth muscle- 
speciﬁc marker proteins SM22 and h1-calponin ( Fig. 1 ), suggesting 
that the increased vasculature did not contribute substantively to the 
observed increase of α-SMA. 
Having excluded smooth muscle as a signiﬁcant source of the 
increased α-SMA in cTnI-ND hearts, myoﬁbroblasts were similarly 
excluded based upon the absence of calponin in cTnI-ND ventricular 
muscle ( Fig. 1 ), and on the absence of visible ﬁbrosis in cTnI-ND hearts 
(unpublished observations). Our data then identiﬁed cardiomyocytes 
as the predominant cellular source of α-SMA in cTnI-ND hearts. The 
expression of α-SMA in adult cTnI-ND cardiomyocytes as an early 
sign of myocardial remodeling represents a fascinating result that 
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Fig. 6. Intracellular localization of α-SMA shows non-complete overlap with the sar- 
comeric protein TnT . Cardiomyocytes from cTnI-ND hearts were immunostained for 
α-SMA (green) and TnT (red), followed by confocal imaging. Image of the cell shows 
apparent overlap of the two antigens across the cell plane. However, enlarged inset 
shows a non-complete overlap of the two antigens within individual sarcomeres, con- 
sistent with a non-identical association with the thin ﬁlaments. (For the interpretation 
of color mentioned in the caption of ﬁgure, the reader is requested to view the online 


















































































 has not previously been described in the literature. Since the primary
functional impact of cTnI-ND is a facilitation of myocardial relaxation
[ 7 ], this mouse line becomes a unique model in which the molecular
mechanisms for diastolic function to induce myocardial remodeling
may be investigated. 
It is important to note that cTnI-ND hearts do not develop hy-
pertrophy or failure during the life span of the animal, and exhibit
beneﬁcial effects on cardiac function with aging [ 8 ]. Early expression
of α-SMA in cTnI-ND cardiomyocytes may therefore be a valid fac-
tor for investigations aimed at understanding pathological cardiomy-
ocyte remodeling. In addition, the increased number of blood vessels
in the cTnI-ND transgenic mouse hearts may represent not only an
early index of cardiac remodeling but also a beneﬁcial adaptation to
improve energetic supply to the cardiomyocytes, a novel hypothesis
worth further investigation. 
3.2. α-SMA distributes to non-myoﬁlament structures in cTnI-ND 
cardiomyocytes 
Further investigation of the subcellular locations of α-SMA led to
its detection within the myoﬁbrils from cTnI-ND hearts, although its
exact effects on cardiomyocyte contractile function will remain to be
studied. Surprisingly, when we isolated myoﬁbrils from these hearts,
we found that they only contained a minor portion (27%) of the α-
SMA expressed in the cTnI-ND heart ( Fig. 5 ), indicative of a limited
role in myoﬁlament contractility. The remaining majority of α-SMA
was either selectively lost from this preparation, or is simply not in
the myoﬁbril preparation along with other known components. The
selective targeting of α-SMA in cardiomyocytes to more than a sin-
gle compartment is interesting given its structural similarity to α-CA.
Despite the signiﬁcant non-myoﬁlament association of α-SMA exhib-
ited biochemically, the immunoﬂuorescence of α-SMA appeared in a
striated pattern ( Fig. 6 ). However, the non-complete overlap observed
with TnT in double labeling microscopy may indicate that while the
sarcomeric portion of α-SMA was concentrated in the actin ﬁlaments
as expected, non-sarcomeric α-SMA was enriched in a zoning pattern
overlapping with the I-band of sarcomeres. 
3.3. Implications for the function of α-SMA during early remodeling in 
non-hypertrophic and non-failing cTnI-ND hearts 
Transient α-SMA expression in developing cardiomyocytes has
been suggested to act as a scaffold for the organization of contractileproteins during the formation of new myoﬁbrils [ 21 ] or during cardiac
differentiation [ 22 , 23 ]. It has also been proposed that α-SMA plays
a role in cellular tension and possibly regulates gene transcription
during embryonic cardiac development [ 24 ]. 
Our ﬁndings reported here suggest that early stages of remod-
eling can precede development of cardiac complications. cTnI-ND
mice exhibit normal life spans with no apparent change in cardiac
morphology, and show functional beneﬁts without evidence of hy-
pertrophy or heart failure [ 5 , 7 ]. Moreover, these hearts show better-
than-wild-type cardiac function at old age (16 months) [ 8 ]. Therefore,
we propose that overexpression of cTnI-ND in mouse hearts may in-
duce additional adaptive changes that contribute to a resetting of the
equilibrium between force generation and relaxation, which in turn
helps constrain myocardial remodeling to the level of physiological
adaptation. 
Besides muscle contraction, actin is essential for many cellular
functions including cell division, adhesion, and migration. Although
isoforms of actin are highly similar with minimal variations in amino
acid sequence, recent ﬁndings suggest that each isoform has a spe-
ciﬁc cellular function [ 10 ]. α-SMA plays an important role in car-
diac sarcomerogenesis, cardiac muscle differentiation, and inﬂuences
cardiomyocyte rhythm [ 24 ]. The signiﬁcant expression of α-SMA in
cTnI-ND hearts may well have multiple functional impacts. 
In summary, functions of N-terminal truncated cTnI in mouse
hearts induced α-SMA expression in cardiomyocytes as an early re-
modeling response. Together with an increase in blood vessel den-
sity, this adaptation may be an early structural response to potent
increases in diastolic function prior to any occurrence of myocardial
hypertrophy. With its limited integration into the contractile appara-
tus, the expression of α-SMA may carry out multiple functional effects
on cardiac function through effects on the cytoskeleton or other ma-
jor non-myoﬁlament compartment. Further studies are required to
fully understand this adaptive regulation. 
4. Experimental procedures 
4.1. Animal models 
Transgenic mice overexpressing cTnI-ND under control of the car-
diac α-myosin heavy chain promoter were previously developed [ 7 ].
One of the cTnI-ND transgenic mouse lines that exhibited early post-
natal expression of the transgene was used to cross with an endoge-
nous cTnI gene deletion line to develop double transgenic mice ex-
pressing 100% cTnI-ND in the adult heart [ 6 ]. Mice used in the present
studies were 2 to 3 months of age and without signs of cardiac hyper-
trophy or heart failure. Age-matched hearts from a double transgenic
mouse line expressing a mutant cTnI on the same endogenous cTnI
gene null background (cTnI-K118C, [ 13 ]) were used as control. 
All animal procedures were approved by the Institutional Animal
Care and Use Committee and were conducted in accordance with the
Guiding Principles in the Care and Use of Animals, as approved by the
Council of the American Physiological Society. 
4.2. SDS–polyacrylamide gel electrophoresis (PAGE) and immunoblot 
analysis 
Total protein was extracted from mouse ventricular muscle by ho-
mogenization of transverse heart blocks in 1% SDS using a PowerGen
1000 tissue homogenizer (Fisher Scientiﬁc). Adult cardiomyocytes
were isolated using a previously established protocol [ 25 –27 ] and
lysed in SDS–PAGE sample buffer (50 mM Tris–HCl, pH 8.8, 2% SDS,
100 mM DTT, 0.1% bromophenol blue, 10% glycerol) [ 5 ]. 
Modiﬁed from a previously described method [ 28 ], mouse ventric-
ular myoﬁbrils were puriﬁed from fresh cardiac muscle after a 3 min
perfusion of the heart with Krebs solution (12.6 mM NaCl, 25 mM
NaHCO 3 , 1.2 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , pH 7.2)

























































containing 50 mM KCl to relax the cardiac muscle. Total myoﬁbril 
rotein was extracted by lysis in SDS–PAGE sample buffer as above. 
The samples were heated at 85 ◦C for 5 min followed by centrifu- 
ation to clarify the supernatant for gel loading. Protein extracts were 
esolved by SDS–PAGE using Laemmli buffer system [ 29 ]. 12% gels 
ith an acrylamide:bisacrylamide ratio of 29:1 was used for analysis 
f calponin and SM22; 14% gels with an acrylamide:bisacrylamide ra- 
io of 180:1 was used for analysis of α-SMA and cTnI. Electrophoretic 
ransfer to nitrocellulose membrane was carried out using standard 
rocedures [ 30 ] using 25 mM phosphate transfer buffer, pH 7.4, and 
ransfer at 2 A for 60 min. The transferred protein bands were visual- 
zed using amido black prior to immunoblot analyses. 
Antibodies and dilutions used in immunoblotting were as fol- 
ows: an anti- α-SMA mouse monoclonal antibody (mAb) from Sigma–
ldrich (A5228) was used at 1:1000 dilution; a rabbit anti-calponin 
olyclonal antibody RAH2 was used at 1:4000; an anti-SM22 mAb 
F6 was used at 1:20; and an anti-TnI mAb TnI-1 was used at 1:2000. 
hosphate-buffered saline (PBS) containing 0.2% Tween-20 (PBS-T) 
as used as the incubation and washing buffers. The blots were then 
etected using horseradish peroxidase (HRP)-conjugated goat anti- 
abbit or anti-mouse IgG second antibody (Jackson ImmunoResearch 
aboratories) at 1:30,000 and developed in ECL Western Blotting Sub- 
trate (Thermo Scientiﬁc) and the signals were revealed with autora- 
iography using BioMax MR ﬁlm (Kodak). Densitometry analysis of 
oomassie Blue stained SDS–PAGE gels, amido black stained nitrocel- 
ulose membranes, and autoradiography ﬁlms was performed on im- 
ges scanned at 500 pixels / in using NIH ImageJ software. Immunoblot 
and intensities were normalized to nitrocellulose protein stain. 
.3. Immunohistochemical analysis 
Fresh hearts from wild type and cTnI-ND mice were ﬂash frozen 
n O.C.T. compound (Fisher Scientiﬁc) and frozen sections were pre- 
ared as previously described [ 31 ]. The sections were incubated with 
% H 2 O 2 at room temperature for 15 min, washed three times with 
BS-T, and incubated with an anti- α-SMA rabbit polyclonal antibody 
AbCam, ab5694) diluted 1:100 in PBS-T at room temperature for 
 h. Following three washes with PBS-T, sections were incubated with 
RP-conjugated goat anti-rabbit antibody diluted 1:2000 in PBS-T at 
oom temperature for 2 h, washed three times again in PBS-T, and de- 
eloped at room temperature in DAB substrate solution (Sigma FAST 
,3 ′ -Diaminobenzidine Tablet set). After washed in water, the sec- 
ions were counter stained with Mayer’s hematoxylin, following the 
anufacturer’s protocol. All sections were mounted under #1 cover 
lip with Permount mounting medium (Fisher Scientiﬁc). The slides 
ere maintained at 4 ◦C for long-term storage. 
The immunohistological images were observed using a Zeiss Ob- 
erver A1 AXIO microscope, and photographed through a 5 × ob- 
ective lens at a resolution of 1.5 pixels / μm. For quantiﬁcation of 
asculature, the complete transverse heart section was reconstructed 
rom a series of overlapping microscope images using the photomerge 
unction in Adobe Photoshop CS5 v12.1. NIH ImageJ software was 
sed to pan around the entire cross-section and count all vesicular 
embranes and to measure the area of each vessel. Measurements 
f the vessel wall area was performed by assuming each vessel had a 
ircular cross section, thus A = πR 2 . The outer diameter of the vessel 
as used to calculate the total area of the cross section and the inside 
adius of the vessel was used to calculate the lumen area. The vessel 
all area was then determined by subtracting the inner area from the 
otal cross sectional area. 
.4. Immunoﬂuorescence microscopy 
Cardiomyocytes isolated from 2 to 3 months old wild type and 
TnI-ND mouse hearts as described above were ﬁxed on #1 glass 
over slips with 4% paraformaldehyde for 15 min, then permeabilized and washed three times in PBS-T before blocked with 1% goat serum in 
PBS-T at room temperature for 60 min. The cardiomyocytes were in- 
cubated with mouse anti- α-SMA mAb (Sigma–Aldrich A5228) diluted 
1:100 at 4 ◦C overnight. Subsequent to a high salt wash (0.5 M NaCl 
in PBS-T, at room temperature for 10 min) and four 15 min washes 
with PBS-T, the cover slips were incubated with Alexa Fluor 488- 
conjugated goat anti-mouse IgG antibody (Life Technologies Corpo- 
ration) diluted at 1:50 at room temperature for 2 h. After four 15-min 
washes, the cardiomyocytes were post-ﬁxed in 4% paraformaldehyde 
for 15 min to preserve staining and mounted on a pre-cleaned mi- 
croscope slide with Prolong Gold Antifade Reagent (Life Technologies 
Corporation). Images were captured using a laser (Point) scanning 
confocal microscope (Leica TCS SP5, excitation using the 458 / 476 / 
488 / 496 / 514 nm multiline Argon laser). Fluorescence intensity anal- 
ysis was performed on images taken with identical camera settings 
using NIH ImageJ software. 
4.5. Data analysis 
All measurements and analysis were performed blinded from the 
animal genotype. Quantitative data are plotted as mean ± SE (stan- 
dard error of the mean, SD / 
√ 
N , where N is number of animals). The 
statistical signiﬁcance of differences was analyzed by two-tailed un- 
paired Student’s t -test. 
Acknowledgements 
We would like to thank Geoff Cady and Hui Wang for technical 
support and genotyping of the transgenic mice. This study was sup- 
ported by NIH / NHLBI grant HL098945 (to J.-P.J.) and an Incubator 
Grant from the Ofﬁce of Vice President for Research, Wayne State 
University (to J.-P.J. and S.C.). 
References 
[1] Perry, S.V. (1999) Troponin I: inhibitor or facilitator. Mol. Cell. Biochem. 190, 
9–32 . 
[2] Jin, J.P., Zhang, Z. and Bautista, J.A. (2008) Isoform diversity, regulation, and 
functional adaptation of troponin and calponin. Crit. Rev. Eukar. Gene Expr. 18, 
93–124 . 
[3] Solaro, R.J., Sheehan, K.A., Lei, M. and Ke, Y. (2010) The curious role of sarcomeric 
proteins in control of diverse processes in cardiac myocytes. J. Gen. Physiol. 136, 
13–19 . 
[4] Yu, Z.B., Zhang, L.F. and Jin, J.P. (2001) A proteolytic NH2-terminal truncation of 
cardiac troponin I that is up-regulated in simulated microgravity. J Biol. Chem. 
276, 15753–15760 . 
[5] Feng, H.Z., Chen, M., Weinstein, L.S. and Jin, J.P. (2008) Removal of the N-terminal 
extension of cardiac troponin I as a functional compensation for impaired my- 
ocardial beta-adrenergic signaling. J. Biol. Chem. 283, 33384–33393 . 
[6] Feng, H.Z., Hossain, M.M., Huang, X.P. and Jin, J.P. (2009) Myoﬁlament incorpo- 
ration determines the stoichiometry of troponin I in transgenic expression and 
the rescue of a null mutation. Arch. Biochem. Biophys. 487, 36–41 . 
[7] Barbato, J.C., Huang, Q.Q., Hossain, M.M., Bond, M. and Jin, J.P. (2005) Prote- 
olytic N-terminal truncation of cardiac troponin I enhances ventricular diastolic 
function. J. Biol. Chem. 280, 6602–6609 . 
[8] Biesiadecki, B.J., Tachampa, K., Yuan, C., Jin, J.P., de Tombe, P.P. and Solaro, R.J. 
(2010) Removal of the cardiac troponin I N-terminal extension improves cardiac 
function in aged mice. J. Biol. Chem. 285, 19688–19698 . 
[9] Black, F.M., Packer, S.E., Parker, T.G., Michael, L.H., Roberts, R., Schwartz, R.J. 
et al. (1991) The vascular smooth muscle alpha-actin gene is reactivated during 
cardiac hypertrophy provoked by load. J. Clin. Invest. 88, 1581–1588 . 
[10] Perrin, B.J. and Ervasti, J.M. (2010) The actin gene family: function follows iso- 
form. Cytoskeleton (Hoboken) 67, 630–634 . 
[11] Schwartz, K., de la Bastie, D., Bouveret, P., Oliviero, P., Alonso, S. and Buckingham, 
M. (1986) Alpha-skeletal muscle actin mRNA’s accumulate in hypertrophied 
adult rat hearts. Circ. Res. 59, 551–555 . 
[12] Suurmeijer, A.J., Clement, S., Francesconi, A., Bocchi, L., Angelini, A., Van Veld- 
huisen, D.J. et al. (2003) Alpha-actin isoform distribution in normal and failing 
human heart: a morphological, morphometric, and biochemical study. J. Pathol. 
199, 387–397 . 
[13] Wei, B., Gao, J., Huang, X.P. and Jin, J.P. (2010) Mutual rescues between two 
dominant negative mutations in cardiac troponin I and cardiac troponin T. J. 
Biol. Chem. 285, 27806–27816 . 




































 [14] Li, L., Miano, J.M., Cserjesi, P. and Olson, E.N. (1996) SM22 alpha, a marker
of adult smooth muscle, is expressed in multiple myogenic lineages during
embryogenesis. Circ. Res. 78, 188–195 . 
[15] Leslie, K.O., Taatjes, D.J., Schwarz, J., vonTurkovich, M. and Low, R.B. (1991) Car-
diac myoﬁbroblasts express alpha smooth muscle actin during right ventricular
pressure overload in the rabbit. Am. J. Pathol. 139, 207–216 . 
[16] Orlandi, A., Hao, H., Ferlosio, A., Clement, S., Hirota, S., Spagnoli, L.G. et al. (2009)
Alpha actin isoforms expression in human and rat adult cardiac conduction
system. Differentiation 77, 360–368 . 
[17] Cohn, J.N., Ferrari, R. and Sharpe, N. (2000) Cardiac remodeling–concepts and
clinical implications: a consensus paper from an international forum on cardiac
remodeling. Behalf of an International Forum on Cardiac Remodeling. J. Am. Coll.
Cardiol. 35, 569–582 . 
[18] Friddle, C.J., Koga, T., Rubin, E.M. and Bristow, J. (2000) Expression proﬁling
reveals distinct sets of genes altered during induction and regression of cardiac
hypertrophy. Proc. Natl. Acad. Sci. USA 97, 6745–6750 . 
[19] Pfeffer, M.A. and Braunwald, E. (1990) Ventricular remodeling after myocardial
infarction. Experimental observations and clinical implications. Circulation. 81,
1161–1172 . 
[20] Swynghedauw, B. (1999) Molecular mechanisms of myocardial remodeling.
Physiol. Rev. 79, 215–262 . 
[21] Donath, M.Y., Zapf, J., Eppenberger-Eberhardt, M., Froesch, E.R. and Eppenberger,
H.M. (1994) Insulin-like growth factor I stimulates myoﬁbril development and
decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc. Natl. Acad.
Sci. USA 91, 1686–1690 . 
[22] Clement, S., Pellieux, C., Chaponnier, C., Pedrazzini, T. and Gabbiani, G. (2001)
Angiotensin II stimulates alpha-skeletal actin expression in cadiomyocytes in
vitro and in vivo in the absence of hypertension. Differentiation 69, 66–74 . [23] Ehler, E., Fowler, V.M. and Perriard, J.C. (2004) Myoﬁbrillogenesis in the devel-
oping chicken heart: role of actin isoforms and of the pointed end actin capping
protein tropomodulin during thin ﬁlament assembly. Dev. Dyn. 229, 745–755 . 
[24] Clement, S., Stouffs, M., Bettiol, E., Kampf, S., Krause, K.H., Chaponnier, C.
et al. (2007) Expression and function of alpha-smooth muscle actin during
embryonic-stem-cell-derived cardiomyocyte differentiation. J. Cell Sci. 120,
229–238 . 
[25] Yu, Z.B., Gao, F., Feng, H.Z. and Jin, J.P. (2007) Differential regulation of myoﬁl-
ament protein isoforms underlying the contractility changes in skeletal muscle
unloading. Am. J. Physiol. Cell Physiol. 292, C1192–C1203 . 
[26] O ’ Connell, T.D., Rodrigo, M.C. and Simpson, P.C. (2007) Isolation and culture of
adult mouse cardiac myocytes. Methods Mol. Biol. 357, 271–296 . 
[27] Yu, Z.B., Wei, H. and Jin, J.P. (2012) Chronic coexistence of two troponin T iso-
forms in adult transgenic mouse cardiomyocytes decreased contractile kinetics
and caused dilatative remodeling. Am. J. Physiol. Cell Physiol. 303, C24–C32 . 
[28] Huang, Q.Q., Brozovich, F.V. and Jin, J.P. (1999) Fast skeletal muscle troponin T
increases the cooperativity of transgenic mouse cardiac muscle contraction. J.
Physiol. 520(Pt 1), 231–242 . 
[29] Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 227, 680–685 . 
[30] Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of pro-
teins from polyacrylamide gels to nitrocellulose sheets: procedure and some
applications. Proc. Natl. Acad. Sci. USA 76, 4350–4354 . 
[31] Jacob, S., Sleiman, N.H., Kern, S., Jones, L.R., Sala-Mercado, J.A., McFarland, T.P.
et al. (2013) Altered calsequestrin glycan processing is common to diverse mod-
els of canine heart failure. Mol. Cell. Biochem. 377, 11–21 . 
